|
⚲
|
| Keyboard |
| Sachs Bruce I
✚
|
|
|---|---|
| CIK # | 0001197036 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001197036] | |
| 5 | [0001197036] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vertex Pharmaceuticals Inc / Ma | |
| Sachs Bruce I |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc / Ma VRTX
Deferred Stock Units · derivative
|
2026-01-15 | Grant | 107.09 | $443.56 | 47,501 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Deferred Stock Units · derivative
|
2025-10-15 | Grant | 115.77 | $410.31 | 47,502 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2025-08-06 | Buy | 1,634 | $389.36 | 636,214 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2025-08-06 | Buy | 3,366 | $389.84 | 1,312,201 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Deferred Stock Units · derivative
|
2025-07-15 | Grant | 101.21 | $469.34 | 47,502 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Stock Option (Right to Buy) · derivative
|
2025-05-01 | Grant | 2,398 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Deferred Stock Units · derivative
|
2025-04-15 | Grant | 95.48 | $497.51 | 47,502 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Deferred Stock Units · derivative
|
2025-01-15 | Grant | 111.65 | $420.31 | 46,928 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Deferred Stock Units · derivative
|
2024-10-15 | Grant | 90.32 | $484.39 | 43,750 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Stock Option (Right to Buy) · derivative
|
2024-08-01 | Option exercise | 5,295 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2024-08-01 | Option exercise | 5,295 | $125.71 | 665,634 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2024-08-01 | Sell | 5,295 | $508.00 | 2,689,860 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Deferred Stock Units · derivative
|
2024-07-15 | Grant | 89.26 | $490.12 | 43,748 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2024-05-22 | Option exercise | 7,073 | $93.51 | 661,396 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2024-05-22 | Sell | 7,073 | $448.00 | 3,168,704 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Stock Option (Right to Buy) · derivative
|
2024-05-22 | Option exercise | 7,073 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Stock Option (Right to Buy) · derivative
|
2024-05-01 | Grant | 3,142 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Deferred Stock Units · derivative
|
2024-04-15 | Grant | 109.49 | $399.58 | 43,750 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Deferred Stock Units · derivative
|
2024-01-12 | Grant | 101.04 | $432.99 | 43,749 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2023-11-06 | Sell | 11,250 | $385.00 | 4,331,250 |
| showing 20 of 192 most recent transactions | |||||